CalAmp Announces Date for Fiscal 2024 Third Quarter Earnings Conference Call
IRVINE, Calif., Dec. 26, 2023 (GLOBE NEWSWIRE) — CalAmp (Nasdaq: CAMP), a leading telematics solution provider that helps organizations improve […]
FINWARD BANCORP ANNOUNCES FOURTH QUARTER DIVIDEND
MUNSTER, Ind., Dec. 26, 2023 (GLOBE NEWSWIRE) — Finward Bancorp (Nasdaq: FNWD) (the “Bancorp” or “Finward”), the holding company for […]
Axogen, Inc. Appoints Kathy Weiler to its Board of Directors
ALACHUA, Fla. and TAMPA, Fla., Dec. 26, 2023 (GLOBE NEWSWIRE) — Axogen, Inc. (NASDAQ: AXGN), a global leader in developing […]
Hudson Acquisition I Corp. Regains Compliance with Nasdaq Listing Rule 5250(c)(1)
NEW YORK, Dec. 26, 2023 (GLOBE NEWSWIRE) — Hudson Acquisition I Corp. (the “Company” or “HUDA”) (Nasdaq: HUDA), today announced […]
Yoshitsu Co., Ltd Receives Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
Tokyo, Japan, Dec. 26, 2023 (GLOBE NEWSWIRE) — Yoshitsu Co., Ltd (“Yoshitsu” or the “Company”) (Nasdaq: TKLF), a retailer and […]
Delisting of Securities of SmileDirectClub, Inc.; Bellerophon Therapeutics, Inc.; Elys Game Technology, Corp.’; Athersys, Inc.; Borqs Technologies, Inc.; ContraFect Corporation; CohBar, Inc.; AgileThought, Inc.; Fat Projects Acquisition Corp.; Evelo Biosciences, Inc.; Troika Media Group, Inc.; Impel Pharmaceuticals Inc.; Fresh Tracks Therapeutics, Inc.; and Near Intelligence, Inc. from The Nasdaq Stock Market
NEW YORK, Dec. 26, 2023 (GLOBE NEWSWIRE) — The Nasdaq Stock Market announced today that it will delist the common stock of […]
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
NEW YORK, Dec. 26, 2023 (GLOBE NEWSWIRE) — LifeMD, Inc.™ (Nasdaq: LFMD), a leading provider of virtual primary care services, today […]
Swvl Reports Receipt of Nasdaq Minimum Bid Price Notification
DUBAI, United Arab Emirates, Dec. 26, 2023 (GLOBE NEWSWIRE) — Swvl Holdings Corp (“Swvl” or the “Company”) (Nasdaq: SWVL), a […]
Coherus Announces FDA Approval of UDENYCA ONBODY™, a Novel and Proprietary State-of-the-Art Delivery System for pegfilgrastim-cbqv
– Innovative design enables five-minute pegfilgrastim delivery time – – Unique, automatic, retractable needle mechanism engineered to maximize safety and […]
Cytokinetics to Host Investor Call on December 27 to Discuss the Topline Results from SEQUOIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Obstructive Hypertrophic Cardiomyopathy
SOUTH SAN FRANCISCO, Calif., Dec. 26, 2023 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that members of its […]
